LUXAW (Lux Health Tech Acquisition) NonCurrent Deferred Liabilities: $12.08 Mil (As of Jun. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUXAW Lux Health Tech Acquisition Corp LUXAW
22 GF Score
Price $0.00
! 1 Warning Sign
View Full Analysis

What is Lux Health Tech Acquisition NonCurrent Deferred Liabilities?

Lux Health Tech Acquisition LUXAW 22 NonCurrent Deferred Liabilities is $12.08 Mil as of Jun. 2022. GuruFocus rates LUXAW with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Lux Health Tech Acquisition's non-current deferred liabilities for the quarter that ended in Jun. 2022 was $12.08 Mil.

Lux Health Tech Acquisition NonCurrent Deferred Liabilities Related Terms

Lux Health Tech Acquisition NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Lux Health Tech Acquisition's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lux Health Tech Acquisition NonCurrent Deferred Liabilities Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
NonCurrent Deferred Liabilities
12.08 12.08

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
NonCurrent Deferred Liabilities Get a 7-Day Free Trial 12.08 12.08 12.08 12.08 12.08
LUXAW
22GF Score
Lux Health Tech Acquisition Corp LUXAW
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $12.08 Mil mean?
Lux Health Tech Acquisition (LUXAW) has a NonCurrent Deferred Liabilities of $12.08 Mil as of Jun. 2022. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Lux Health Tech Acquisition and its competitors.
Is Lux Health Tech Acquisition's NonCurrent Deferred Liabilities too high?
Lux Health Tech Acquisition's current NonCurrent Deferred Liabilities is $12.08 Mil. Overall, Lux Health Tech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Lux Health Tech Acquisition's NonCurrent Deferred Liabilities compare to BFAC and FRXB?
Lux Health Tech Acquisition's NonCurrent Deferred Liabilities of $12.08 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Diversified Financial Services company?
A good NonCurrent Deferred Liabilities depends on the Diversified Financial Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Lux Health Tech Acquisition and its competitors. Lux Health Tech Acquisition's current NonCurrent Deferred Liabilities is $12.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lux Health Tech Acquisition stock overvalued right now?
Lux Health Tech Acquisition (LUXAW) has a current NonCurrent Deferred Liabilities of $12.08 Mil. The current NonCurrent Deferred Liabilities is $12.08 Mil. Lux Health Tech Acquisition's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Lux Health Tech Acquisition (LUXAW), the current NonCurrent Deferred Liabilities is $12.08 Mil as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lux Health Tech Acquisition Business Description

Address 920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for LUXAW

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price